-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
7 Biotech and Health Care Stocks to Buy
Biotechnology and health care companies are growing at an alarming rate. Do not miss the boat on some of fastest-growing companies among them.
Acquisitions, Strong Sales Keep Pfizer Dividend Strong
Despite stagnant revenue growth, good operating margins for Pfizer (NYSE:PFE) leaves room for cash-generating dividends for investors.
Ariad Pharmaceuticals Still Might Have Upside
Ariad Pharmaceuticals is up 120% in the past 12 months, mostly fueled on optimism over its trial leukemia treatment. But some analysts think the ceiling is higher.
Amgen CEO Says ‘I’m Leaving.’ Investors Say ‘Good Riddance’
After a decade as CEO, the oft-maligned Kevin Sharer will step down. That's giving shareholders holiday cheer as they bid the stock up on the news.
Amgen Getting Its Groove Back
As its CEO steps down, Amgen stock is breaking out. See the target for AMGN.
Researcher: J&J/Pharmacyclics Drug Could Be a Game-Changer
The experimental cancer drug Johnson & Johnson bought last week is receiving high praise, and could be "paradigm-shifting."
Covidien Follows Abbott With a Pharma Spin-Off
Could Sanofi, Novartis or GlaxoSmithKline be next to separate pharmaceutical development into a stand-alone company?
7 Feel-Good Pharma Stocks to Buy
Medicine is something few people can afford to go without during times of recession, making these pharma companies good sources of stability.
Pfizer Delivers Early Holiday Gifts to Shareholders
The company brings holiday cheer with its new stock repurchase program and dividend boost.
5 Winners in 2011 That Could Repeat in ’12
These S&P 500 standouts are poised for sequels in the coming year. All have a target price at least 11% higher than recent trading.
Is Danaher the Next Berkshire Hathaway?
This steadily growing company is a well-diversified player in tech and life sciences. See who we think could be the tech version of Berkshire.
Abbott Labs Spinoff Looks Like the Right Move
Shareholders would likely be better served by the company's prescription drug business standing alone. Here's why.
Intuitive Surgical Shares Are In the Pink
Shares have surged as the company continues to be the dominant player in a fast-growing health care sector.
Invest in the Biggest Trend in Health Care Now
This company is at the forefront of one of the top trends in health care. See the name you should be buying.
Why Eli Lilly Could Be a Lottery Stock Pick
If Eli Lilly is successful in delaying the progression of Alzheimer’s disease with its experimental drug, it could make Lipitor look like a mid-sized product. The odds?
5 Small-Cap Buys With Large Potential
Small cap stocks can be very risky, but very rewarding. These 5 do everything from mining to groceries -- and they can deliver big profits.
10 Game-Changing Health Care Stocks to Buy
These 10 diverse stocks are likely to improve their earnings and stock prices in 2012. Take a look.
Top 5 Emerging Growth Stocks for December
Louis Navellier's top five emerging growth stocks for December include standouts such as Jazz Pharmaceuticals and Hansen Natural Corp.
Affymax Shares Hang on an FDA Decision
Affymax's stock price is swinging wildly as investors await a ruling on the company's promising kidney disease drug.
